BAM66388 PF-2341066 Inhibitor of the c-Met kinase and the NPM-ALK. PF-2341066 inhibited cell proliferation in ALK-positive ALCL cells (IC50s=30 nM). Quantity Price 10 mg 110.00 50 mg 370.00 100 mg 650.00 200 mg 950.00                 C21H22Cl2FN5O 877399-52-5 97+% MFCD12407409

BAM66390 XL184 XL184 (Cabozantinib) is a potent multitargeted VEGFR2, Met, FLT3, Tie2, Kit and Ret inhibitor with IC50 of 0.035, 1.8, 14.4, 14.3 and 4.6 nM for VEGFR2, Met, FLT3, Tie2 and Kit, respectively. Quantity Price 10 mg 120.00 50 mg 470.00 200 mg 1470.00                     C28H24FN3O5 849217-68-1 98+% MFCD17010276

BAM66388 Crizotinib Inhibitor of the c-Met kinase and the NPM-ALK. PF-2341066 inhibited cell proliferation in ALK-positive ALCL cells (IC50s=30 nM). Quantity Price 10 mg 110.00 50 mg 370.00 100 mg 650.00 200 mg 950.00                 C21H22Cl2FN5O 877399-52-5 97+% MFCD12407409

BAM66390 Cabozantinib XL184 (Cabozantinib) is a potent multitargeted VEGFR2, Met, FLT3, Tie2, Kit and Ret inhibitor with IC50 of 0.035, 1.8, 14.4, 14.3 and 4.6 nM for VEGFR2, Met, FLT3, Tie2 and Kit, respectively. Quantity Price 10 mg 120.00 50 mg 470.00 200 mg 1470.00                     C28H24FN3O5 849217-68-1 98+% MFCD17010276

BAM66390 BMS-907351 XL184 (Cabozantinib) is a potent multitargeted VEGFR2, Met, FLT3, Tie2, Kit and Ret inhibitor with IC50 of 0.035, 1.8, 14.4, 14.3 and 4.6 nM for VEGFR2, Met, FLT3, Tie2 and Kit, respectively. Quantity Price 10 mg 120.00 50 mg 470.00 200 mg 1470.00                     C28H24FN3O5 849217-68-1 98+% MFCD17010276

[1/2]